| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.089 | 0.07 |